Basal subtypes have been reported to possess more cytotoxic lymphocytes and NK cell infiltration, and may be more sensitive to immunotherapy.[35] This is consistent with our previous finding that S100A5 shaped a non‐inflamed phenotype of BLCA in terms of the molecular subtypes of BLCA. The gene discussed is S100A5; the disease is bladder transitional cell carcinoma.